Radu Vasilcanu

721 total citations
9 papers, 622 citations indexed

About

Radu Vasilcanu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Radu Vasilcanu has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Oncology. Recurrent topics in Radu Vasilcanu's work include Growth Hormone and Insulin-like Growth Factors (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). Radu Vasilcanu is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Ubiquitin and proteasome pathways (3 papers). Radu Vasilcanu collaborates with scholars based in Sweden and United States. Radu Vasilcanu's co-authors include Leonard Girnita, Olle Larsson, Bita Sehat, Daiana Vasilcanu, Ada Girnita, Robert J. Lefkowitz, Sudha K. Shenoy, Ada Girnita, Magnus Axelson and Sandra Andersson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Radu Vasilcanu

9 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radu Vasilcanu Sweden 9 498 245 138 96 80 9 622
Daiana Vasilcanu Sweden 10 357 0.7× 214 0.9× 107 0.8× 77 0.8× 39 0.5× 12 493
Claire Worrall Sweden 12 339 0.7× 144 0.6× 94 0.7× 94 1.0× 47 0.6× 17 513
Caitrin Crudden Sweden 12 324 0.7× 77 0.3× 124 0.9× 83 0.9× 23 0.3× 17 419
Michael Boesl Germany 7 335 0.7× 55 0.2× 38 0.3× 94 1.0× 42 0.5× 8 585
Stefania Santopietro Italy 9 481 1.0× 123 0.5× 136 1.0× 147 1.5× 28 0.3× 9 612
Kazuyasu Ohta Japan 8 341 0.7× 338 1.4× 132 1.0× 161 1.7× 22 0.3× 9 628
Evelina Mele Italy 9 336 0.7× 89 0.4× 93 0.7× 68 0.7× 75 0.9× 10 575
Steve G. Kovats United States 3 336 0.7× 119 0.5× 164 1.2× 65 0.7× 46 0.6× 4 637
A Ando Japan 10 939 1.9× 107 0.4× 68 0.5× 104 1.1× 45 0.6× 11 1.1k
Huiyuan Zheng Sweden 10 234 0.5× 58 0.2× 73 0.5× 58 0.6× 32 0.4× 18 405

Countries citing papers authored by Radu Vasilcanu

Since Specialization
Citations

This map shows the geographic impact of Radu Vasilcanu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radu Vasilcanu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radu Vasilcanu more than expected).

Fields of papers citing papers by Radu Vasilcanu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radu Vasilcanu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radu Vasilcanu. The network helps show where Radu Vasilcanu may publish in the future.

Co-authorship network of co-authors of Radu Vasilcanu

This figure shows the co-authorship network connecting the top 25 collaborators of Radu Vasilcanu. A scholar is included among the top collaborators of Radu Vasilcanu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radu Vasilcanu. Radu Vasilcanu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sehat, Bita, Sandra Andersson, Radu Vasilcanu, Leonard Girnita, & Olle Larsson. (2007). Role of Ubiquitination in IGF-1 Receptor Signaling and Degradation. PLoS ONE. 2(4). e340–e340. 64 indexed citations
2.
Vasilcanu, Radu, Daiana Vasilcanu, Bita Sehat, et al.. (2007). Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin. Molecular Pharmacology. 73(3). 930–939. 37 indexed citations
3.
Girnita, Leonard, Sudha K. Shenoy, Bita Sehat, et al.. (2007). β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression. Journal of Biological Chemistry. 282(15). 11329–11338. 116 indexed citations
4.
Vasilcanu, Radu, Lars Rosengren, Bita Sehat, et al.. (2007). Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1. Oncogene. 27(11). 1629–1638. 67 indexed citations
5.
Vasilcanu, Daiana, Radu Vasilcanu, Bita Sehat, et al.. (2006). IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R−). Biochemical and Biophysical Research Communications. 347(4). 1059–1066. 20 indexed citations
6.
Girnita, Leonard, Sudha K. Shenoy, Bita Sehat, et al.. (2005). β-Arrestin Is Crucial for Ubiquitination and Down-regulation of the Insulin-like Growth Factor-1 Receptor by Acting as Adaptor for the MDM2 E3 Ligase. Journal of Biological Chemistry. 280(26). 24412–24419. 142 indexed citations
7.
Girnita, Ada, Weng‐Onn Lui, Radu Vasilcanu, et al.. (2005). The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection. Oncogene. 25(22). 3186–3195. 40 indexed citations
8.
9.
Vasilcanu, Daiana, Ada Girnita, Leonard Girnita, et al.. (2004). Vasilcanu D, Girnita A, Girnita L, Vasilcanu R, Axelson M, Larsson O.. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway. Oncogene 23: 7854-7862. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daiana Vasilcanu Breakdown of academic impact, for papers by Claire Worrall Breakdown of academic impact, for papers by Caitrin Crudden Breakdown of academic impact, for papers by Michael Boesl Breakdown of academic impact, for papers by Stefania Santopietro Breakdown of academic impact, for papers by Kazuyasu Ohta Breakdown of academic impact, for papers by Evelina Mele Breakdown of academic impact, for papers by Steve G. Kovats Breakdown of academic impact, for papers by A Ando Breakdown of academic impact, for papers by Huiyuan Zheng
Rankless by CCL
2026